Demo Sign up Log In

Celldex Therapeutics Inc (CLDX)

Cost of Revenue

$63.79M

TTM · Period ending: Jun 30, 2026 · USD

CLDX Cost of Revenue

Latest reported$63.79Mperiod endingJun 30, 2026

Latest reported$63.79Mperiod endingJun 30, 2026

CLDX TTM Cost of Revenue ($0.00 → $63.79M)

TTM cost of revenue

High-resolution chart · PNG

CLDX cost of revenue history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Celldex Therapeutics Inc Cost of Revenue — Trailing twelve months (TTM) (USD)
Period ending	Cost of Revenue (USD)
Jun 30, 2001	-868,700
Mar 31, 2001	-1,038,300
Dec 31, 2000	-689,300
Sep 30, 2000	-620,700
Jun 30, 2000	-759,500
Mar 31, 2000	-698,100
Dec 31, 1999	-712,800
Sep 30, 1999	-600,000
Jun 30, 1999	-500,000
Mar 31, 1999	-500,000
Dec 31, 1998	-400,000
Sep 30, 1998	-400,000
Jun 30, 1998	-300,000
Mar 31, 1998	-300,000
Dec 31, 1997	-300,000
Sep 30, 1997	-300,000
Jun 30, 1997	-400,000
Mar 31, 1997	-400,000
Dec 31, 1996	-100,000
Sep 30, 1996	100,000
Jun 30, 1996	700,000
Mar 31, 1996	1,200,000
Dec 31, 1995	1,300,000
Sep 30, 1995	1,400,000
Jun 30, 1995	1,300,000
Mar 31, 1995	1,300,000
Dec 31, 1994	1,300,000
Sep 30, 1994	1,500,000
Jun 30, 1994	1,500,000
Mar 31, 1994	1,400,000
Dec 31, 1993	1,400,000
Sep 30, 1993	1,000,000
Jun 30, 1993	1,100,000
Mar 31, 1993	1,000,000
Oct 31, 1992	1,000,000
Jul 31, 1992	1,200,000
Apr 30, 1992	1,100,000
Jan 31, 1992	1,300,000
Oct 31, 1991	1,300,000
Jul 31, 1991	1,200,000
Apr 30, 1991	1,200,000
Jan 31, 1991	1,000,000
Oct 31, 1990	1,000,000
Jul 31, 1990	800,000
Apr 30, 1990	500,000
Jan 31, 1990	300,000
Oct 31, 1989	0
Jul 31, 1989	0
Apr 30, 1989	0
Jan 31, 1989	0
Oct 31, 1988	0
Jul 31, 1988	0
Apr 30, 1988	0
Jan 31, 1988	0
Oct 31, 1987	0
Jul 31, 1987	0
Apr 30, 1987	0
Jan 31, 1987	0
Oct 31, 1986	0
Jul 31, 1986	0

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.